CHAMPIONS ONCOLOGY, INC.
For the period ended Jul 31, 2025. Filed Sep 15, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jul 31, 2025 · Filed Sep 15, 2025
CSBR$4.84+1.0%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
None.
Item 6. Exhibits
| No. | Exhibit |
| 10.1 | Employment Agreement between Champions Oncology, Inc. and Robert Brainin, effective as of July 16, 2025 (incorporated by reference to Exhibit 10.1 of the Current Report on Form 8-K, filed with the SEC on July 21, 2025) |
| 31.1* | Section 302 Certification of Principal Executive Officer |
| 31.2* | Section 302 Certification of Principal Financial Officer |
| 32.1** | Certification Pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |
| 101.INS* | iXBRL Instance Document. |
|---|---|
| 101.SCH* | iXBRL Taxonomy Extension Schema Document. |
| 101.CAL* | iXBRL Taxonomy Extension Calculation Linkbase Document. |
| 101.DEF* | iXBRL Taxonomy Extension Definition Linkbase Document. |
| 101.LAB* | iXBRL Taxonomy Extension Label Linkbase Document. |
| 101.PRE* | iXBRL Taxonomy Extension Presentation Linkbase Document. |
- filed herewith
** furnished herewith
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.